TP53 and myelodysplastic syndrome: By multivariable analysis, PHANTM combined phenotype score as a categorical variable, dichotomized at the median (over 1 vs. equal or less than 1), was found to be an independent prognostic factor in the patients with TP53 mutated MDS, along with other factors analyzed, including IPSS-R and having two TP53 mutations.